Annals of Surgical Oncology

, Volume 12, Issue 1, pp 65–71

Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin

  • Vic J. Verwaal
  • Serge van Ruth
  • Arjen Witkamp
  • Henk Boot
  • Gooike van Slooten
  • Frans A. N. Zoetmulder
Original Article



Peritoneal carcinomatosis of colorectal cancer is probably best treated by cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). In The Netherlands Cancer Institute, this treatment has been performed since 1995. The long tradition of this treatment enabled us to study long-term survival in detail.


Between 1995 and 2003, 117 patients were treated by cytoreduction and HIPEC. The aim of the cytoreduction was to remove all visible tumor. After the cytoreduction, the abdomen was perfused with mitomycin C (35 mg/m2) at 40°C to 41°C for 90 minutes. Survival was calculated by the Kaplan-Meier method. Survival was also analyzed for the following subgroups: no residual tumor, residual tumor ≤2.5 mm, and more residual tumor. Hazard ratios for each of the seven abdominal regions were calculated to determine the influence on survival.


The median survival was 21.8 months. The 1-, 3-, and 5-year survival rates were 75%, 28%, and 19%, respectively. The Kaplan-Meier curve reached a plateau of 18% at 54 months. In 59 patients a complete cytoreduction was achieved, and in 41 patients there was minimal residual disease. The median survival of these patient groups was 42.9 and 17.4 months, respectively. When gross macroscopic tumor was left behind, as was the case in 17 patients, the median survival was 5 months. Involvement of the small bowel before cytoreduction was associated with poorer outcome.


Cytoreduction followed by HIPEC showed a median survival of 21 months. From 3 years on, a consistent group of 18% of patients stayed alive.


Colorectal cancer Peritoneal carcinomatosis HIPEC Long-term survival 


  1. 1.
    Sugarbaker, PH 1993

    Peritoneal carcinomatosis

    Wanebo, HJ eds. Colorectal CancerMosbySt. Louis42836
    Google Scholar
  2. 2.
    Carraro, PG, Segala, M, Cesana, BM, Tiberio, G 2001Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgeryDis Colon Rectum4424350PubMedGoogle Scholar
  3. 3.
    Jayne, DG, Fook, S, Loi, C, Seow-Choen, F 2002Peritoneal carcinomatosis from colorectal cancerBr J Surg89154550PubMedGoogle Scholar
  4. 4.
    Russell, AH, Pelton, J, Reheis, CE, Wisbeck, WM, Tong, DY, Dawson, LE 1985Adenocarcinoma of the colon: an autopsy study with implications for new therapeutic strategiesCancer56144651PubMedGoogle Scholar
  5. 5.
    Sadeghi, B, Arvieux, C, Glehen, O,  et al. 2000Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective studyCancer8835863PubMedGoogle Scholar
  6. 6.
    Shen, P, Levine, EA, Hall, J,  et al. 2003Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosisArch Surg1382633CrossRefPubMedGoogle Scholar
  7. 7.
    Sticca, RP 2003Peritoneal carcinomatosis: a final frontierAnn Surg Oncol104845CrossRefPubMedGoogle Scholar
  8. 8.
    Sugarbaker, PH 2003Carcinomatosis—is cure an option?J Clin Oncol217624PubMedGoogle Scholar
  9. 9.
    Elias, D, Blot, F, El Otmany, A,  et al. 2001Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapyCancer92716CrossRefPubMedGoogle Scholar
  10. 10.
    Loggie, BW, Fleming, RA, McQuellon, RP, Russell, GB, Geisinger, KR 2000Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal originAm Surg665618PubMedGoogle Scholar
  11. 11.
    Piso, P, Bektas, H, Werner, U,  et al. 2001Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinomaEur J Surg Oncol2728690CrossRefPubMedGoogle Scholar
  12. 12.
    Verwaal, VJ, Van Ruth, S, de Bree, E,  et al. 2003Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancerJ Clin Oncol21373743CrossRefPubMedGoogle Scholar
  13. 13.
    Verwaal, VJ, Tinteren, H, Ruth, S, Zoetmulder, FAN 2004Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyJ Surg Oncol85617PubMedGoogle Scholar
  14. 14.
    Essquivel, J, Vidal-Jove, J, Steves, MA, Sugarbaker, PH 1993Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapySurgery1136316Google Scholar
  15. 15.
    Loggie, BW, Fleming, RA 1996

    Complications of heated intraperitoneal chemotherapy and strategies for prevention

    Sugarbaker, PH eds. Peritoneal Carcinomatosis: Principles of ManagementKluwer AcademicBoston22133
    Google Scholar
  16. 16.
    Sugarbaker, PH 1995Peritonectomy proceduresAnn Surg2212942PubMedCrossRefGoogle Scholar
  17. 17.
    Witkamp, AJ, de Bree, E, Van Goethem, R, Zoetmulder, FA 2001Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapyCancer Treat Rev2736574PubMedGoogle Scholar
  18. 18.
    Laufman, LR, Krzeczowski, KA, Roach, R, Segal, M 1987Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancerJ Clin Oncol51394400PubMedGoogle Scholar
  19. 19.
    Iveson, TJ, Hickish, T, Schmitt, C, Cutsem, E 1999Irinotecan in second-line treatment of metastatic colorectal cancer: improved survival and cost-effect compared with infusional 5-FUEur J Cancer351796804PubMedGoogle Scholar
  20. 20.
    Shimada, Y, Rougier, P, Pitot, H 1996Efficacy of CPT-11 (irinotecan) as a single agent in metastatic colorectal cancerEur J Cancer32AS137PubMedGoogle Scholar
  21. 21.
    Sugarbaker, PH, Chang, D 1999Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancyAnn Surg Oncol672731PubMedGoogle Scholar
  22. 22.
    Beaujard, AC, Glehen, O, Caillot, JL,  et al. 2000Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosisCancer8825129PubMedGoogle Scholar
  23. 23.
    Cavaliere, F, Perri, P, Di Filippo, F,  et al. 2000Treatment of peritoneal carcinomatosis with intent to cureJ Surg Oncol74414PubMedGoogle Scholar
  24. 24.
    Verwaal, VJ, Tinteren, H, Ruth, S, Zoetmulder, FAN 2004Predicting survival of peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intra-peritoneal chemotherapyBr J Surg9173946PubMedGoogle Scholar
  25. 25.
    McQuellon, RP, Loggie, BW, Fleming, RA, Russell, GB, Lehman, AB, Rambo, TD 2001Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosisEur J Surg Oncol276573CrossRefPubMedGoogle Scholar
  26. 26.
    McQuellon, RP, Loggie, BW, Lehman, AB,  et al. 2003Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosisAnn Surg Oncol1015562CrossRefPubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2004

Authors and Affiliations

  • Vic J. Verwaal
    • 1
  • Serge van Ruth
    • 1
  • Arjen Witkamp
    • 1
  • Henk Boot
    • 2
  • Gooike van Slooten
    • 1
  • Frans A. N. Zoetmulder
    • 1
  1. 1.Department of SurgeryThe Netherlands Cancer InstituteAmsterdamThe Netherlands
  2. 2.Department of GastroenterologyThe Netherlands Cancer InstituteAmsterdamThe Netherlands

Personalised recommendations